STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: We found for the first time that ART could suppress constitutive STAT5 activation in CML and that these effects were specific to STAT5 activation at Tyr694/699, as ART had no effect on the expression of total STAT5 protein.